Cite
HARVARD Citation
Duan, W. et al. (2021). The loss or absence of minimal residual disease of <0·1% at any time after two cycles of consolidation chemotherapy in CBFB–MYH11‐positive acute myeloid leukaemia indicates poor prognosis. British journal of haematology. pp. 265-271. [Online].